Addressing Barriers to Healthcare Transitions for Survivors of Childhood and Adolescent Cancers (R01 Clinical Trial Optional)
Closed Posted
- Opportunity number
- RFA-CA-25-019
- Agency
-
National Institutes of Health
Department of Health and Human Services
- Applications due
- Award size
- Not on record
Opportunity facts
- Assistance listings
-
- 93.399 Cancer Control
- Funding instrument
- Grant
- Categories
-
- Education
- Health
- Eligible applicants
-
- For Profit Organizations
- Public or Indian Housing Auth.
- County Governments
- Small Businesses
- Non-501(c)(3) Nonprofits
- City/Township Governments
- Higher Education Inst. (Public)
- Higher Education Inst. (Private)
- Tribal Organizations (Not Federally Recognized)
- Independent School Districts
- 501(c)(3) Nonprofits
- State Governments
- Special District Governments
- Other
- Tribal Governments (Federally Recognized)
- Points of contact
-
- NIH OER Webmaster grantsinfo@nih.gov
- Full announcement
Opportunity details come from Grants.gov. Updated .
About this opportunity
The National Cancer Institute (NCI), part of the Department of Health and Human Services National Institutes of Health, is seeking research proposals through this R01 grant opportunity focused on developing multi-level intervention studies addressing healthcare transition barriers for childhood and adolescent cancer survivors. The funding opportunity aims to support the development and testing of interventions that promote high-quality transitional care and ensure continued engagement of cancer survivors in appropriate adult healthcare surveillance. Eligible applicants include for-profit organizations, nonprofits, higher education institutions, government entities, and tribal organizations. Evaluation criteria will assess scientific merit, experimental design, investigator competency, available resources, budget necessity, and relevance to program objectives. The proposal submission deadline is December 9, 2025, with the grant opportunity officially posted on December 16, 2024.
While specific award amounts are not explicitly stated, the Cancer Control program (CFDA 93.399) has historically awarded grants ranging from approximately $434,954 to $23,393,810. The research is expected to produce critical evidence for establishing best practices and standards of care for transitioning childhood cancer survivors to adult healthcare systems. The performance period for these grants typically spans 2-7 years, with initial awards providing funds for the first 12-month budget period. Research can be conducted at the applicant's institutional facilities, with potential collaborative efforts across multiple research sites and healthcare systems.
Synopsis
Through this Funding Opportunity Announcement (FOA), the NCI intends to support multi-level intervention studies that address individual and system level barriers to transition from pediatric to adult care for survivors of childhood and adolescent cancers. The goal of this opportunity is to support the development and testing of interventions and strategies that promote high-quality transitional care and continued engagement of survivors of childhood and adolescent cancers to ensure these survivors receive appropriate surveillance and care into adulthood. Overall, it is anticipated that this research will provide critical evidence for establishing best practices and standards of care that can be widely disseminated and adopted.
Files
| File | Type | Posted |
|---|---|---|
| RFA-CA-25-019-Full-Announcement.html | HTML file |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar grant opportunities
- Ask GovTribe AI about this opportunity